Rapid advances in high-throughput sequencing technology have led to the generation of a large number of multi-omics biological datasets. Integrating data from different omics provides an unprecedented opportunity to gain insight into disease mechanisms from different perspectives. However, integrative analysis and predictive modeling from multi-omics data are facing three major challenges: i) heavy noises; ii) the high dimensions compared to the small samples; iii) data heterogeneity. Current multi-omics data integration approaches have some limitations and are susceptible to heavy noise. In this paper, we present MSPL, a robust supervised multi-omics data integration method that simultaneously identifies significant multi-omics signatures during the integration process and predicts the cancer subtypes. The proposed method not only inherits the generalization performance of self-paced learning but also leverages the properties of multi-omics data containing correlated information to interactively recommend high-confidence samples for model training. We demonstrate the capabilities of MSPL using simulated data and five multi-omics biological datasets, integrating up three omics to identify potential biological signatures, and evaluating the performance compared to state-of-the-art methods in binary and multi-class classification problems. Our proposed model makes multi-omics data integration more systematic and expands its range of applications.
I. INTRODUCTION
Driven by the development of new high-throughput sequencing techniques, various types of biological data with different formats, sizes, and structures have been increasing at an unprecedented rate. Gene expression, miRNA expression, proteins, DNA methylation and metabolites are some examples of biological data produced by using high-throughput techniques such as microarray [1] and mass spectrometry [2] . Generally, each of these distinct biological data types provides different, partially independent and complementary information of the entire genome [3] . Therefore, deciphering complex human genomes and gene functions may require more complete and complementary information than those are provided by single type of data. The integration of multi-omics data (e.g. genomics, transcriptomics, proteomics and metabolomics, etc.) provides an unprecedented opportu-The associate editor coordinating the review of this manuscript and approving it for publication was Donato Impedovo . nity to gain insight into complex disease mechanisms from different views and levels, predict the subtype of the target disease, and discover potential multi-omics biological signatures [4] - [6] .
Effective methods to integrative analysis and predictive modeling from multi-omics data have to overcome at least three computational challenges. i) High levels of noise and collection bias present in each type of biological data. Random noise and system/collection bias exist in distinct biological data types not only impact the cost and effectiveness of scientific research, but also disrupt precise prediction of disease subtypes that may ultimately impact patients [7] . Moreover, different noise and bias across distinct data types may result in reduced classifier performance and finding unreliable potential biological signatures [8] . ii) The high dimensions compared to the small samples. The biological data generally contains a large number of features p and small size of samples n, which is called large p and small n problem [9] . From the biological perspective, only a small fraction VOLUME 7, 2019 This work is licensed under a Creative Commons Attribution 4.0 License. For more information, see http://creativecommons.org/licenses/by/4.0/ of features that are highly correlated to the target disease and most of the features are irrelevant. From the machine learning perspective, numerous irrelevant features may prone to overfitting issue and negatively impact the performance of the classifier [10] , [11] . iii) Data heterogeneity. Distinct types of biological data generated from different omics platforms possess heterogeneous information, such as following different statistical distributions, suffering from different levels of imprecisions and containing different kinds of uncertainties [12] . Unfortunately, current multi-omics data integration approaches have yet to address all of these computational challenges together [5] . Therefore, there is an urgent need for a robust method for integrative analysis multi-omics data. The problem of learning predictive models from multiomics data can be naturally considered a multimodal learning problem [13] , [14] . Commonly, data from multiple modalities contain more complete and complementary information of the object than that is provided by the single modality only. Multi-omics data provides multiple modalities with distinct feature sets in the same set of samples. Current supervised multimodal data integration approaches for predicting cancer subtypes and identifying significant multi-omics signatures can be classified as concatenation-based, ensemble-based, and knowledge-driven approaches [15] .
The concatenation-based approach simply combines all features from different types of data into a single large dataset before. And after that, prediction and feature selection are based on a single statistical model [5] , [16] . The ensemblebased approach constructs a prediction model on each omics dataset separately and utilizes an average/majority voting scheme to combine the results of prediction [17] . These approaches can be biased towards certain omics data types, and do not consider interactions between omic layers [18] , [19] . Recently, classification methods such as Generalized Elastic Net (EN) [20] , [21] , adaptive Group-Regularized ridge regression [22] , and sparse Partial Least Squares Discriminant Analysis (sPLSDA) [23] have incorporated curated biological data such as genetic pathway data, methylation data, and gene expression data. These methods are still limited to single omics data such that, either the concatenationbased or ensemble-based strategy needs to be applied to incorporate additional omics data types. However, neither of these two types of data integration approaches considers the interaction between multiple data types, which limits the understanding of the relationship between different levels of biological function.
Knowledge-driven multimodal data integration considers the relationships between different modalities based on prior knowledge. Very recently, Singh et al. [15] proposed Data Integration Analysis for Biomarker discovery using Latent cOmponents (DIABLO), which is dedicated to maximizing the correlated information between multiple omics data. DIA-BLO actually extends the sparse generalized canonical correlation analysis (SGCCA) [24] to the supervised classification model. It is a multivariate dimension reduction approach that maximizes the covariance between linear combinations of variables from multiple omics according to the given design matrix and combines all potential components for prediction. However, the assumption of a linear relationship between selected significant omics features may not be applicable to some biological research areas. In addition, DIABLO is susceptible to heavy noise, resulting in poor generalization performance.
In this paper, we present MSPL, a robust supervised multimodal method that simultaneously identifies significant multi-omics signatures during the integration process and predicts the cancer subtypes. MSPL (Multimodal Self-Paced Learning) adopts a sample reweighting strategy to improve the robustness of the learning process in heavy noise situations. The core idea of MSPL is to interactively recommend high-confidence samples with smaller loss values between multiple omic data types, and automatically select samples from easy to complex to train the model for each modality in a purely self-paced way. Our method is actually established on the self-paced learning (SPL) regime [25] , and is a variant of it. Furthermore, to overcome the overfitting issue caused by large p and small n problem, MSPL embeds a regularization method to perform feature selection during the learning process. A series of regularization methods for feature selection have been proposed [26] - [30] . Here, MSPL is performed via L 1 regularization [26] . In the proposed method, MSPL strives to address the three above-mentioned computational challenges faced by integrative analysis and predictive modeling from multi-omics data.
We demonstrate the capability of MSPL and compare its prediction and feature selection performance with other stateof-the-art methods using simulated data and five publicly available multi-omics datasets, including four benchmark cancer datasets and one breast cancer multi-omics dataset. In particular, breast cancer multi-omics dataset has approximately 1000 samples, including four breast cancer subtypes.
In these experiments, we integrate up to three omics datasets and evaluate the performance of all competing methods in binary and multi-class classification problems. The results show that MSPL presents competitive performance with existing methods, especially robust in the presence of heavy noises.
The rest of this paper is organized as follows. Section II introduces the related work of self-paced learning, while Section III presents the proposed MSPL algorithm. Experimental results of several competing methods and brief biological analysis are shown in Section IV. A conclusion is given in Section V. Finally, the linkage of this paper code is provided in Section V.
II. RELATED WORK
This section introduces the fundamental concepts of curriculum learning and self-paced learning.
A. CURRICULUM LEARNING
The fundamental definition of Curriculum Learning (CL) was first proposed by [31] . Inspired by human and animal learning mechanism, learning is better when the samples are organized in a meaningful order, that is start with easier concepts to progressively more complex ones. This learning mechanism gradually included samples from easy to complex correspond to courses that are studied at different stages of the human or animals. CL can accelerate convergence to the global minimum and has been proven by empirical evaluation to help alleviate local optimal problems in nonconvex optimization [32] , [33] . The main challenge for CL is to identify the easy and complex samples during the learning process. However, providing the ranking of samples may be conceptually difficult for human in many real-world applications. Moreover, what is intuitively ''easy'' for a human may not be in accordance with what is easy for the algorithm in the feature and hypothesis space applied in the given application [25] .
B. SELF-PACED LEARNING
To alleviate the deficiency of CL, Kumar et al. [25] first proposed Self-Paced Learning (SPL). SPL embeds CL (from easy to progressively more complex samples) as a regularization term into the model learning process. Formally, suppose given a dataset D = {(x 1 , y 1 ) , (x 2 , y 2 ) , . . . , (x n , y n )}, where x i = x i1 , x i2 , . . . , x ip is the i-th input sample with p features and y i is the i-th sample with the value 0 or 1 in the classification model. Let L(y i , f (x i , β)) denotes the loss function, which calculates the loss between the real label y i and the estimated value f (x i , β). The β represents the model parameter inside the decision function f (x i , β). The purpose of the SPL is to jointly learn the model parameter β and the latent weight variable v = [v 1 , v 2 , . . . , v n ] by minimizing:
where γ is an age parameter for controlling the learning pace, λ is the L 1 regularizer parameter and g(v, γ ) represents the self-paced regularizer (SP-regularizer). The traditional objective of SPL is to simultaneously minimize the weighted loss function and the negative
. The Alternative Optimization Strategy (AOS) algorithm can effectively solve the SPL problem. It is a biconvex optimization iterative algorithm that divides features used for optimization into two disjoint blocks. The basic procedure of AOS algorithm can be described as: in each iteration, to optimize the target block of features while keeping the other block fixed. For the traditional SPL problem, when latent weight variable v is fixed, the optimal model parameter β can be obtained by the state-of-the-art supervised learning approaches. When β is fixed, the optimal weight variable v * = [v * 1 , v * 2 , . . . , v * n ] can be calculated by [25] :
This alternative search strategy implies an intuitive explanation: (1) When updating v with a fixed β, if the loss value of the sample is smaller than the age parameter γ , then the sample is selected as an easy sample (v i = 1) for the classifier training, otherwise, do not select (v i = 0). (2) When updating β with a fixed v, the classifier is trained only on the selected easy samples (v i = 1). (3) Before starting the next iteration, increase the age parameter γ to control the learning pace, which allows more samples to be used for model training.
When γ is small, only easy sample with smaller loss will be selected. With the increase of age parameter γ , more samples with larger loss will be gradually selected to train a more ''mature'' model. By jointly learning the model parameters β and the latent weight variable v = [v 1 , v 2 , . . . , v n ], gradually increasing the age parameter γ , SPL can automatically include more samples (from easy to progressively more complex) in the training process with a purely self-paced way. Various machine learning applications provide empirical validation that SPL can be performed robustly in the presence of heavy noises [34] - [36] . Moreover, SPL is also widely used in softmax regression [37] , multi-view learning [38] , multitask learning [39] , etc. In addition, [40] proved the intrinsic working mechanism of SPL, which naturally explains the effectiveness of SPL, especially its robustness in heavy noises.
III. PROPOSED METHOD
This section presents the proposed Multimodal Self-paced Learning (MSPL). The objective of MSPL is first formally defined, and then we present an efficient algorithm to solve the model.
A. THE MSPL MODEL
Multi-omics data naturally has multimodal properties. Multimodal data typically contains more complete description and complementary information than those of single modality. An intuitive way to achieve this is to select samples through the interrelationship between multiple modalities. We assume that the different modalities share common knowledge of sample confidence. In a word, samples with high quality in one omics may be consistent with other omics.
The objective of MSPL can be mathematically described as follows. Suppose given a multimodal dataset
features under the j-th modality. p (j) indicates the number of features in the j-th modality. y i is the common label of the i-th sample for every modality in the classification model (e.g. y i = {0, 1} in the binary classification problem). Let L(y i , f (x (j) i , β (j) )) denotes the loss function, which calculates the loss between the real label y i and the estimated value f (x
). The objective function of VOLUME 7, 2019 MSPL can be expressed as:
where m denotes the total number of modalities. x (j) i is the ith input sample (i = 1, 2, . . . , n) under the j-th modality, and y i is the corresponding label of x
i . λ is a tuning parameter, it controls the complexity of the model. γ (j) indicates the age parameter, it controls the learning pace in each iteration in the j-th modality. δ is the parameter that controls influence from other modalities when one modality tends to select more training samples.
The proposed MSPL model actually corresponds to the sum of the SPL model under multiple modalities plus a regularization term 1≤k,j≤m (j) . This inner product encodes the relationship between multiple modalities. The new regularizer actually establishes attribute links between multiple modalities by using multimodal data of a sample. It takes advantage of the information content of multimodal data and selects high confident samples through the interrelationship between multiple modalities. Therefore, this new regularizer enforces the weight penalizing the loss of one modality similar to that of other modalities (e.g. a sample with high confidence in one modality is likely the same in other modalities). In addition, each modality of data uses high confident samples to identify potential significant features, which can improve the feature selection performance of the model.
B. THE MSPL ALGORITHM
The proposed MSPL model can be solved by the alternative optimization strategy (AOS) algorithm, as listed in Algorithm 1.
Initialization: Initialize weight parameter v (j) i , age parameter γ (j) and δ. v (1) , v (2) , . . . , v (m) are zero vectors in R m . γ (1) , γ (2) , . . . , γ (m) are initialized with small values to include few samples in the first iteration of the training process. Set δ to a specific value through the whole learning process. The initial loss of all samples in each modality is obtained by simultaneously training multiple classifiers on all samples of different modalities.
Update v (k) i (k = 1, 2, . . . , m; k = j): This step can obtain the current optimal weight of samples under the k-th modality. Due to the multimodal data intrinsically contains complementary information. Therefore, the physical meaning of this step is to prepare the confident samples (v (k) i > 0) for training on the j-th modality. That is, a high confident sample can be selected by the interrelationship between multiple modalities. Based on Equation (3), the first order derivative at v (k) i can be estimate as:
According to Equation (4), the current optimal weight of the i-th sample under the k-th modality can be expressed as:
Update v (j) i : The purpose of this step is to formally define which samples will be confirmed into the training process of the j-th modality. The optimal weight of the i-th sample under the j-th modality can be calculated in the same way as the previous step. Different from the previous step is that the samples selected in this step will be directly employed for training in the j-th modality. According to Equation (5), it is easy to observe that the samples with high confidence from other modalities possess higher chance of being selected for the training of the j-th modality than other samples.
Update β (j) : The purpose of this step is to train a classifier using the selected samples in the j-th modality. In this work, we select the sparse logistic regression classifier to train the model. In this step, Equation (3) degenerates into the standard sparse logistic regression optimization problem as:
where 1 < n (j) ≤ n. n (j) represents the current number of samples used to train a classifier under the j-th modality. This problem can be readily solved by R package glmnet [41] .
Before the start of the next iteration, age parameters γ (j) (j = 1, 2, . . . , m) are increased to allow more samples with larger loss values to enter the next iteration of the training process. We then repeat the above optimization process for different modalities until all samples are used for model training or reach the maximum number of iterations.
From Algorithm 1, we can easily observe that it can obtain the optimal solution under interaction with multiple modalities and the time complexity of it is O(n 2 × p), where n p. In the test phase, suppose given a test dataset
with m modalities, where u is the number of test sample. By using the optimal solution of a classifier under each modality β (1) , β (2) , . . . , β (m) to predict the optimal y k , which can be predicted by the following minimization problem:
Algorithm n (each sample has m modalities), labels y 1 , . . . , y n , age parameters γ (1) , . . . , γ (m) , δ and max_iter. 2: Output: β (1) , . . . , β (m) . 3: Initialize v (1) , . . . , v (m) , γ (1) , . . . , γ (m) and δ 4: Update β (1) , . . . , β (m) 5: iter = 1 6: while iter ≤ max_iter do 7: for j ← 1 to m do 8: for k ← 1 to m and k = j do 9: Update v Update v (j) i : Confirm which samples will be feeded into the training process of the j-th modality 12: Update β (j) : Train a classifier (e.g. sparse logistic regression model) under the j-th modality 13: end for 14: Augment γ (1) , . . . , γ (m) 15: iter ← iter + 1 16: end while 17: Return β (1) , . . . , β (m)
C. ALGORITHM ANALYSIS
The proposed MSPL algorithm, as shown in Algorithm 1, mainly differs from current multi-omics data integration approaches in the following four-fold aspects: 1) Instead of ''simple and brute'' aggregating multi-omics data into a single dataset (e.g. concatenation-based) or ignoring the interrelationship between multiple omic data types (e.g. ensemble-based), the MSPL algorithm uses multimodal interactions to recommend high confident samples to train the model. In MSPL, if the i-th sample in the k-th modality that loss value is smaller than a confidence threshold γ (k)
and will be selected to train the classifier in the k-th modality. Note that this confidence threshold is related to the age parameter γ (k) in the k-th modality and weight of the corresponding samples in other modalities. It implies that we more prefer to select a sample that is high confidence in other modalities than a sample that is not in it. High confident samples are selected between multiple modalities to take full advantages of comprehensive information to characterize an object. 2) When updating samples for training in one modality, in addition to selecting high confident samples that are recommended by other modalities, the MSPL algorithm may picks few high confident samples with very small loss values on the current modality. This strategy preserves some specific characteristics of each modality.
3) For the ensemble-based data integration and DIABLO, both of them apply a majority/average voting scheme during performance evaluation and test dataset prediction. The MSPL algorithm, inspired by [42] , predicts the subtype of a sample by solving the minimization problem according to Equation (7) . The prediction can be performed more accurately by calculating the sum of the predicted loss values under multiple classifiers. 4) The proposed MSPL model is a variant of the SPL learning regime, which gradually increases the learning pace and automatically select more samples (from smaller losses to progressively larger losses) to train the model and obtain a more ''mature'' model. Meng et al. [40] from the mathematical perspective have proven the effectiveness of the SPL learning regime, especially its robustness in heavy noises situation. Therefore, MSPL achieves a better generalization performance than traditional multimodal data integration methods (see results part).
IV. RESULTS
We evaluate the capability of the proposed MSPL model and compare its performance with other state-of-the-art methods in this section. We applied the logistic regression model/multinomial model with Elastic Net (EN) regularization [27] , Random Forest (RF) [43] and Self-paced Learning (SPL) with L 1 penalty [25] in the concatenation and ensemble frameworks. The compared methods include: concatenation-based methods (Concate_EN, Concate_RF, and Concate_SPL), ensemble-based methods (Ensemble_EN, Ensemble_RF, and Ensemble_SPL) and DIABLO [15] .
A. SIMULATIONS
We evaluate the robustness and feature selection performance of our proposed MSPL model in simulated experiments with varying noise control parameters and sample sizes.
1) GENERATE SIMULATED DATA
We generate multimodal data with small sample sizes and high dimensionality, and each modality contains a large number of irrelevant features [10] . Beyond that, different modalities with varying dimensionality. We generated the predictor vectors x i1 , x i2 , . . . , x ip (i = 1, . . . , n) independently by the standard normal distribution, where p is the number of features. x i = x i1 , x i2 , . . . , x ip denotes the i-th sample. The simulated dataset is generated by the logistic regression model and is generated by the follows [11] , [44] :
where ε = (ε 1 , ε 2 , . . . , ε n ) T is the independent random errors generated by N (0, 4) , σ is the noise control parameter. Simulated data are generated by the above procedure. Three simulated datasets (A, B, C) for two classes Y were We consider the cases with varying training samples size n = 100, 150, 200 and varying noise control parameters σ = 0, 0.4, 0.8, respectively. Each method was evaluated on a test dataset with 100 samples. For the Concate_EN, Con-cate_SPL, Ensemble_EN, Ensemble_SPL and MSPL methods, we used 10-fold cross-validation to obtain the optimal tuning parameter λ in the sparse logistic regression model. The simulated experiments were repeated 30 times and we report the average measurement.
2) ANALYSIS OF SIMULATION
We demonstrate the average test accuracy of each competing method for each simulated experiment in Table 1 To better illustrate the robustness of the proposed MSPL method towards heavy noises situation, we exhibit the tendency curves of the training and test AUC of different methods on simulated experiments with varying noises parameters and sample sizes in Fig. 1. From this figure, we can easily conclude that the Concate_RF and Concate_RF can readily overfit to the high dimensionality with small sample sizes situation. Beyond that, it can be seen that gaps in predict performance between MSPL and all other methods increase as the training sample sizes deceased with the high noise parameter σ = 0.8. That is, the robustness of our method outperforms other competing methods in the case of small sample sizes with heavy noise. For instance, with the training sample size n = 100, our method achieves more than 6% AUC gain compared with the second best results under noise parameter σ = 0.8. When the training samples size n increases, the prediction performance of all the methods are improved.
We also evaluate the feature selection performance of each competing method on simulated experiments with varying noise parameters and samples sizes. The β-sensitivity and βspecificity are used to evaluate the feature selection performance, defined as follows [45] : 
where the |·| 0 represents the number of non-zero elements in a vector. The logical not operators of β andβ areβ andβ, respectively. And . * is the element-wise product. As shown in Table 2 , it can be obviously seen that our method gets the best β-sensitivity performance across all cases of simulated experiments. With the training sample size n = 100, our method attains more than about 10% βsensitivity gain compared with the second best results under all noise parameters. It implies that our method is superior to other competing methods in identifying significant features. For the β-specificity, Concate_EN and DIABLO achieve the best and second best results. The proposed MSPL method performs slightly worse than these two methods. Although Concate_EN and Concate_SPL achieved the excellent β-specificity performance in simulated experiments, concatenation-based methods have an imbalance problem for the identified multimodal features (See real dataset experiments part). 
B. REAL DATASET EXPERIMENTS
We first compare our proposed method with seven other methods on four benchmark cancer datasets. In addition, we curated approximately 1000 samples from breast cancer multi-omics study, including four cancer subtypes. We use breast cancer multi-omics dataset to evaluate the performance of all competing methods in multi-class classification problem. Besides, we further analyze the significant multi-omics signatures identified by our proposed method in breast cancer data.
1) BENCHMARK CANCER DATASETS
Four benchmark multi-omics cancer datasets (mRNA, miRNA and DNA methylation) were obtained from [5] : Glioblastoma multi-forme (GBM), Kidney renal clear cell carcinoma (KRCCC), Lung squamous cell carcinoma (LSCC), Colon adenocarcinoma (COAD). Survival times were provided for each disease cohort by [5] . By using the median survival time, we dichotomized the samples into two classes in low and high survival times. A brief description of these four benchmark datasets is summarized in Table 3 .
2) ANALYSIS ON BENCHMARK DATASETS
We evaluate the prediction and feature selection performance of the eight methods on benchmark cancer datasets using random partition. We randomly divide the datasets that approximate 70% of the datasets as the training samples and the rest as the test samples. We repeated the experiments 30 times, and report the average measurement. Fig. 2 plots the box plot analysis of training and test accuracy calculated on four benchmark cancer datasets under 30 repetitions. For training accuracy, all methods get desirable results, except the DIABLO. For instance, the average training accuracy of DIABLO is 74.78%, 77.52% and 79.56% in three datasets GBM, KRCCC and LSCC respectively, while other methods have reached more than 90%. For the test accuracy, it can be easily seen that our method performs best performance across all benchmark datasets. Our method demonstrates the best generalization performance, it attains approximate 5% test accuracy gain compared with other methods in almost all benchmark datasets, except the LSCC dataset. Moreover, methods with self-paced learning have better generalization performance than the corresponding without self-paced learning. For example, the average accuracy of Ensemble_SPL is superior to Ensemble_EN in all benchmark datasets. Fig. 3 indicates the number of significant multi-omics signatures identified by all methods in the benchmark datasets. From the figure, we can easily find that the concatenationbased methods tend to be biased towards the more predictive signatures (mRNA and methylation). For instance, in KRCCC dataset, the average number of signatures of mRNA, miRNA and methylation selected by the Con-cate_EN are 14.37, 0.17 and 22.67, respectively. Compared to other omics significant features of mRNA and methylation, the concatenation-based methods almost failed to select the significant miRNA. Our proposed MSPL method, DIABLO and ensemble-based methods are robust in multi-omics feature selection.
3) BREAST CANCER MULTI-OMICS DATASET
We curated breast cancer multi-omics dataset (mRNA, miRNA and methylation) from the Cancer Genome Atlas (TCGA, data version 2015_11_01 for BRCA) [46] in order to achieve a systems characterization of breast cancer subtypes with multiple omics. This dataset contains four subtypes of breast cancer: Luminal A (LumA), Luminal B (LumB), Her2enriched (Her2) and Basal-like (Basal), which have been reported the most replicated subtypes of human breast cancer [47] . The miRNA dataset was derived from two different Normalization and pre-processing were used to clean the original multi-omics breast cancer dataset. Each omics data was normalized to log2-counts per million (logCPM) [48] . After normalization, we removed genes that counted to 0 in 70% of the samples. And the pre-processing of miRNA transcripts and methylation was the same as the mRNA. Besides that, we removed PAM50 labels in mRNA according to the [15] . Original and pre-processed breast cancer multiomics data are described in Table 4 . Table 5 demonstrates the number of each subtype in breast cancer dataset used to the training and test dataset.
4) ANALYSIS ON BREAST CANCER DATASETS
We evaluate the prediction performance of the eight methods in multiple cancer subtypes classification. Classification accuracy and Cohen's kappa (KAPPA) [49] are used as indicators for evaluating all methods. As shown in Table 6 , we can conclude that the Concate_RF and the Ensemble_RF methods easily overfit to the training dataset, whose test accuracy and KAPPA are inferior to other methods, except for DIA-BLO. For the DIABLO method, the accuracy and KAPPA of the training and test dataset are both worst compared with other methods. While our method gets the third best result in the training dataset, it is less prone to overfitting issue, the test KAPPA achieves over 81%, which higher than other methods. Fig. 4 shows the normalized confusion matrix to visualize the test performance of all methods. Since sample sizes of each subtype are an imbalance, we normalized the confusion matrix so that it contains only numbers between 0 and 1. It can be seen more intuitively from the figure that our method performs better than other methods in multi-class classification. For Concate_RF and Ensemble_RF, there is huge confusion of Her2 with other subtypes. Meanwhile, they are difficult to distinguish between LumA and LumB. The Concate_EN and Ensemble_EN methods also make it difficult to distinguish Her2 with other subtypes. Compared to Concate_EN and Ensemble_EN, Concat_SPL and Ensemble _SPL have improved in distinguishing Her2 and LumB, but inferior to DIABLO and our method. Although MSPL with slightly weak separation of Her2 and LumB compared to DIABLO, DIABLO is confused with LumA and LumB, and only 63% of the samples are correctly predicted to be LumA. This is significantly worse than other competing methods. Tables 7, 8 and 9 summarize the 20 top-ranked significant features of mRNA, miRNA and methylation identified by all methods in breast cancer dataset, respectively. According to these three tables, we can intuitively find that the biological features selected by the concatenation-based methods are still unbalanced, consistent with the results of previous experiments. To explore the multi-omics features that are selected by MSPL in depth, we examine the interplay between 20 top-ranked selected features by our method. Fig. 5 shows the interactive network of the 20 topranked features of mRNA and methylation selected by MSPL. We construct an integrative network of interactions among these features using the cBioPortal [50] , [51] by integrating the biological interaction from publicly breast cancer dataset (METABRIC [52] , [53] ). Fig. 5 shows that mRNA features IGBP1, GATA3, FZD9, CKS1B, CHEK2 and methylation features ELK4, HMGA2, PREX1, EFNA3 in the maximum interactive network, which are connected to other frequently altered genes. In particular, GATA binding protein 3 (GATA3) is frequently mutated in breast cancer [54] and it is a critical transcription factor in mammary gland development and differentiation [55] . Checkpoint kinase 2 (CHEK2) is a tumor suppressor gene, which is a key component of the DNA damage-signaling pathway [56] . CHEK2 pathogenic variants are associated with breast cancer and colorectal families, and the risk of developing breast cancer is higher in carries of CHEK2 mutations [57] . Expression of high mobility group AT-hook 2(HMGA2) in cancer is associated with poor prognosis for patients. In the latest research, [58] suggest that HMGA2 is an attractive therapeutic target for com- bination therapies using DNA damaging drugs. Moreover, CHEK2 and CKS1B are targeted by several cancer drugs. In other small networks of Fig. 5 , there are several genes are connected to other frequently altered genes associated with breast cancer. For instance, MUC1 has been used in clinical practice as a serum tumor marker (CA15-3) for monitoring recurrence and response to the treatment of breast cancers [59] . Besides, we can easily find that SUOX, CDKL1, MUC1, SLC7A11 and CA12 are targeted by several cancer drugs, the yellow hexagon represents FDA approved drug targets gene.
We also use circos plot to present correlations between features identified by MSPL in Fig. 6 . We use a Pearson correlation coefficient to calculate the association between features. The association between features is shown as a color link inside the figure to indicate a positive or negative correlation. Fig. 6 shows the balance of multi-omics significant features selected in our method. And, we construct an interactive network of the high correlation features from mRNA and methylation according to the 20 top-ranked Pearson correlation values. Fig. 7 demonstrates the maximum interactive network between these features, mRNA features AURKA, CDKN3, FAT2, HASPIN, SPC25 and methylation features FGG and TAS2R13 in the same interactive network and linked to other frequently altered genes. AURKA is a molecular barrier to the efficacy of PI3K-pathway inhibitors in breast cancer [60] , [61] . And [62] discovered a novel AURKA-MEK1 interaction in breast cancer cells as a potential therapeutic target. Reference [63] found that SPC25 expression is quite high in basal-like subtype compared with other subtypes.
These above mentioned multi-omics features demonstrate that our proposed MSPL method can efficiently and robustly identify significant multi-omics signatures associated with breast cancer. MSPL not only efficiently selects signatures with high correlations between multi-omics, but also successfully identifies significant biological signatures that are associated with other frequently altered breast cancer genes.
V. CONCLUSION
Driven by technological advances, large-scale molecular omics datasets are in strong need of integrative machine learning methods for better utilize the multiple sources data to gain insight into complex biological systems from different levels and the development of predictive models. However, heavy noises, large p and small n problem, and data heterogeneity of omics data present significant computational challenges in applying the state-of-the-art machine learning methods for integrative analysis and predictive modeling from multi-omics data. In this paper, we propose a novel multi-omics data integration method MSPL that simultaneously identifies significant multi-omics signatures during the integration process and predicts the cancer subtypes. Compared with current state-of-the-art methods, our method performs robust in the presence of heavy noises and possesses excellent generalization performance. In addition, our method achieves the best performance in both binary and multi-class classification problems. Moreover, the proposed method also can work well on other classifiers (e.g. Support Vector Machine (SVM)). At last, the significant multi-omics signatures selected by our method in breast cancer multiomics dataset are introduced in detail, which verifies the effectiveness and robustness of our method in feature selection. This work in progress is aimed at further developing effective machine learning method for integrative analysis and predictive modeling from multi-omics data, and discover potential biological signatures. This learning mechanism is hopeful to be extended to other multimodal problems and expands its range of applications.
